Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes

2006/04/18 by Tomoya Mita, Hirotaka Watada, Takeshi Ogihara +7 · 29 citations
Chemistry · Medicine · Nursing · #Biochemistry #Cardiology #Cardiovascular Disease and Adiposity #Cardiovascular Health and Disease Prevention #Carotid arteries #Chemistry #Diabetes mellitus #Eicosapentaenoic acid #Endocrinology #Fatty Acid Research and Health #Fatty acid #Internal medicine #Intima-media thickness #Medicine #Polyunsaturated fatty acid #Type 2 diabetes

paper · doi:10.1016/j.atherosclerosis.2006.03.005

openalex publication_date 2006/04/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Cited by

• Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study
• Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
• Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease
• Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials
• Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. [europepmc]
• Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. [europepmc]
• Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: Implications for carotid interventions. [europepmc]
• Omega-3 fatty acids and cognitive function in women. [europepmc]
• n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. [europepmc]
• Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. [europepmc]
• Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study. [europepmc]
• Essential fatty acids as functional components of foods- a review. [europepmc]
• Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan. [europepmc]
• Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall. [europepmc]
• The Association between Cerebral White Matter Lesions and Plasma Omega-3 to Omega-6 Polyunsaturated Fatty Acids Ratio to Cognitive Impairment Development. [europepmc]
• Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products. [europepmc]
• Eicosapentaenoic acid and 5-HEPE enhance macrophage-mediated Treg induction in mice. [europepmc]
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. [europepmc]
• Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. [europepmc]
• Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium density in Japanese men. [europepmc]
• Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. [europepmc]
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. [europepmc]
• Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. [europepmc]
• Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. [europepmc]
• The Benefits of Omega-3 Fats for Stabilizing and Remodeling Atherosclerosis. [europepmc]
• Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid. [europepmc]
• Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial. [europepmc]
• Position Statement on Fat Consumption and Cardiovascular Health - 2021. [europepmc]
• Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials. [europepmc]